SCHEMBL1576044

SCHEMBL1576044

COc1ccc(CN2CCN(C3CN(C(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)C3)CC2)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.58
SHMT2 P34897 1/20 0.49
PRKAB2 O43741 5/20 0.47
PRKAG1 P54619 5/20 0.47
PRKAA2 P54646 5/20 0.47
PRKAA1 Q13131 5/20 0.47
PRKAG3 Q9UGI9 5/20 0.47
PRKAG2 Q9UGJ0 5/20 0.47
PRKAB1 Q9Y478 5/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
KDM4E B2RXH2 2/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.46
MAPT P10636 1/20 0.45
TRPV6 Q9H1D0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1575484 0.93 FAAH (0.49) FAAHSHMT2PRKAB2PRKAG1PRKAA2
SCHEMBL1575675 0.93 FAAH (0.49) FAAHSHMT2PRKAB2PRKAG1PRKAA2
SCHEMBL1574816 0.91 FAAH (0.55) FAAHKMT2AMEN1KDM4EMAPK1
SCHEMBL1574923 0.90 FAAH (0.48) FAAHSHMT2PRKAB2PRKAG1PRKAA2
SCHEMBL1574840 0.90 MEN1 (0.47) FAAHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL1575324 0.89 PRKAB2 (0.60) FAAHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL1576231 0.88 FAAH (0.59) FAAHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL1575591 0.86 FAAH (0.61) FAAHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL1575395 0.86 FAAH (0.60) FAAHPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL1576012 0.86 POLB (0.45) FAAHSHMT2PRKAB2PRKAG1PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308562-A2 Azetidine ring compounds and drugs comprising the same Ono Pharmaceutical Co., Ltd. (JP) 2011-04-13 EP disclosed
US-7511159-B2 Azetidine ring compounds and drugs comprising the same ONO PHARMACEUTICAL CO., LTD. (JP) 2009-03-31 US disclosed
US-20070135402-A1 Azetidine ring compounds and drugs comprising the same ONO PHARMACEUTICAL CO., LTD. (JP) 2007-06-14 US disclosed
EP-1698375-A1 AZETIDINE RING COMPOUNDS AND DRUGS COMPRISING THE SAME ONO PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135402-A1 Azetidine ring compounds and drugs comprising the same EDNRA, LIPG, EDNRB FAAH 3484/4885SHMT2 700/4885PRKAB2 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.